DD137584A5 - Verfahren zur herstellung von 4-hydroxy-2-benzimidazolinon-derivaten - Google Patents

Verfahren zur herstellung von 4-hydroxy-2-benzimidazolinon-derivaten

Info

Publication number
DD137584A5
DD137584A5 DD78207192A DD20719278A DD137584A5 DD 137584 A5 DD137584 A5 DD 137584A5 DD 78207192 A DD78207192 A DD 78207192A DD 20719278 A DD20719278 A DD 20719278A DD 137584 A5 DD137584 A5 DD 137584A5
Authority
DD
German Democratic Republic
Prior art keywords
hydroxy
preparing
benzimidazolinone derivatives
benzimidazolinone
derivatives
Prior art date
Application number
DD78207192A
Other languages
English (en)
Inventor
Carl H Ross
Walter-Gunar Friebe
Wolfgang Kampe
Wolfgang Bartsch
Egon Roesch
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19782801953 external-priority patent/DE2801953A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DD137584A5 publication Critical patent/DD137584A5/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DD78207192A 1977-08-12 1978-08-09 Verfahren zur herstellung von 4-hydroxy-2-benzimidazolinon-derivaten DD137584A5 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2736295 1977-08-12
DE19782801953 DE2801953A1 (de) 1978-01-18 1978-01-18 4-hydroxy-2-benzimidazolinon-derivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
DD137584A5 true DD137584A5 (de) 1979-09-12

Family

ID=25772515

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78207192A DD137584A5 (de) 1977-08-12 1978-08-09 Verfahren zur herstellung von 4-hydroxy-2-benzimidazolinon-derivaten

Country Status (14)

Country Link
US (1) US4367235A (de)
EP (1) EP0000784B1 (de)
JP (1) JPS5432467A (de)
AT (1) AT364831B (de)
AU (1) AU3888578A (de)
CA (1) CA1108619A (de)
DD (1) DD137584A5 (de)
DE (1) DE2860981D1 (de)
DK (1) DK355378A (de)
ES (1) ES472435A1 (de)
FI (1) FI782452A (de)
IL (1) IL55315A0 (de)
IT (1) IT7826640A0 (de)
PT (1) PT68404A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0178413A1 (de) * 1984-08-17 1986-04-23 Beecham Group Plc Benzimidazole
US4554287A (en) * 1984-09-12 1985-11-19 Smithkline Beckman Corporation Antihypertensive 7-[2-(dialkylamino)ethyl]-4-hydroxy-1,3-benzimidazol-2-ones
JPS63156809A (ja) * 1986-12-19 1988-06-29 Shin Etsu Chem Co Ltd 塩化ビニル系重合体の製造方法
CA2085844A1 (en) * 1991-12-27 1993-06-28 Nobuyuki Hamanaka Fused benzeneoxyacetic acid derivatives
WO1995004047A1 (en) * 1993-07-31 1995-02-09 Smithkline Beecham Plc 2-benzoheterocyclyloxy or thiopropanolamine derivatives with adreno receptor agonist activity
ZA967892B (en) * 1995-09-21 1998-03-18 Lilly Co Eli Selective β3 adrenergic agonists.
ES2171839T3 (es) 1996-09-05 2002-09-16 Lilly Co Eli Analogos de carbazol como agonistas adrenergicos selectivos de beta3.
US5808080A (en) * 1996-09-05 1998-09-15 Eli Lilly And Company Selective β3 adrenergic agonists
CO5011072A1 (es) 1997-12-05 2001-02-28 Lilly Co Eli Etanolaminas pirazinil substituidas como agfonistas de los receptores
CN103445428A (zh) * 2012-05-28 2013-12-18 苏州科羽电子技术服务有限公司 一种车座手提袋

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081447A (en) * 1975-04-09 1978-03-28 Abbott Laboratories 5-[2-Hydroxy-3-(3,4-dimethoxy phenethylamino)]-propoxy-3,4-dihydro carbostyril and pharmaceutically acceptable salts thereof
CH624395A5 (de) * 1976-01-08 1981-07-31 Ciba Geigy Ag

Also Published As

Publication number Publication date
AT364831B (de) 1981-11-25
EP0000784A1 (de) 1979-02-21
ES472435A1 (es) 1979-04-16
DK355378A (da) 1979-02-13
JPS5432467A (en) 1979-03-09
AU3888578A (en) 1980-02-21
FI782452A (fi) 1979-02-13
ATA582978A (de) 1981-04-15
IL55315A0 (en) 1978-10-31
US4367235A (en) 1983-01-04
DE2860981D1 (en) 1981-11-19
EP0000784B1 (de) 1981-08-26
PT68404A (de) 1978-09-01
CA1108619A (en) 1981-09-08
IT7826640A0 (it) 1978-08-09

Similar Documents

Publication Publication Date Title
DD137107A5 (de) Verfahren zur herstellung von spiro-hydantoinderivaten
AT362782B (de) Verfahren zur herstellung von 4-hydroxypyrrolidin-2-on-derivaten
DD135380A5 (de) Verfahren zur herstellung von 4-acylamino-phenyl-aethanolaminen
DD135500A5 (de) Verfahren zur herstellung von polyaetheramid-saeuren
AT362781B (de) Verfahren zur herstellung von 4-hydroxypyrrolidin-2-on-derivaten
DD138904A5 (de) Verfahren zur herstellung von prostanderivaten
DD139256A5 (de) Verfahren zur herstellung von substituierten diaminoanthrachinonen
DD135482A5 (de) Verfahren zur herstellung von p-benzochinon
DD138651A5 (de) Verfahren zur herstellung von alpha-fluormethyl-alpha-amino-alkansaeuren
DD135383A5 (de) Verfahren zur herstellung von 1-azolyl-3,3-dimethyl-1-phenoxy-butan-2-onen
DD137584A5 (de) Verfahren zur herstellung von 4-hydroxy-2-benzimidazolinon-derivaten
DD135488A5 (de) Verfahren zur herstellung von pyridazinon-derivaten
DD134089A5 (de) Verfahren zur herstellung von 4-diphenylmethylen-1-hydroxybenzylpiperidinen
DD137926A5 (de) Verfahren zur herstellung von n-substituierten alpha-ketocarbonsaeureamiden
PT71741B (de) Verfahren zur herstellung von tetrahydrochinolinderivaten
DD131562A5 (de) Verfahren zur herstellung von 5-pregnen-derivaten
ATA55178A (de) Verfahren zur herstellung von 1alpha-hydroxy- -cholesterin-derivaten
DD138202A5 (de) Verfahren zur herstellung von veraetherten cycloalkanolen
DD122961A5 (de) Verfahren zur herstellung von diphenylaether-derivaten
AT363625B (de) Verfahren zur herstellung von 21-hydroxy-20methyl-pregnan-derivaten
AT366695B (de) Verfahren zur herstellung von 3-brommethyl-3cephemsulfoxydderivaten
DD134524A5 (de) Verfahren zur herstellung von 1-oxadethiacephamverbindungen
DD135908A5 (de) Verfahren zur herstellung von halogenarylmalonamidooxacephalosporinen
DD131178A1 (de) Verfahren zur herstellung alpha-cyanidsubstituierter styrylfarbstoffe
AT368500B (de) Verfahren zur herstellung von ergolin-derivaten